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The scoping review of Chinese and Western medicine treatment of 
diabetic foot in Asia 
 
Abstract 
Background of Study: Diabetic foot is a common and serious chronic 
complication of diabetes due to the simultaneous occurrence of diabetic peripheral 
neuropathy and vascular lesion. Among all complications, foot ulcers in diabetic 
ulcers account for the first place among the reasons for hospitalization and treatment 
of diabetic patients. 15% of diabetic patients may have foot diseases, and 85% of 
patients may have foot ulcers as the cause of amputation. Diabetic foot seriously 
affects the quality of life of patients. Although there are many methods to treat 
diabetic foot, the therapeutic effect of diabetic foot is not ideal in 
general.Objectives:The main purpose of this scoping review was analyzing the 
existing loopholes of researches on diabetic foot in Asia.Methods:Used PubMed, 
CNKI, Wangfangdata, CQVIP to search and select 5 traditional Chinese medicine 
literature and 5 western medicine literature, through the comparison of various 
conditions between literature to analyze the lack of research.Result and 
Discussion:10 pieces of literature were retained through 183 records and included 9 
drugs or decoction, they were adipose-derived stem cell–hydrogel complex, 
hyperbaric oxygen therapy, Xenogeneic(porcine) acellular dermal matrix, alprostadil, 
salvia miltiorrhiza polyphenols for injection and collagen sponge, TaohongSiwu 
Decoction, Simiao Yong＇ an Decoction, Jiawei Simiao Yong＇ an Decoction, 
HuangqiGuizhiWuwu Tang, and WuweiXiaodu Drink. The obvious problems found 
by this scoping review were the quantity and quality deficiency of the research in the 
diabetic foot in Asia. Conclusion: Scoping review is an effective method of evidence 
identification and synthesis, which can provide a basis for the further development of 
acertain field. In the further study of the diabetic foot, more attention should be paid 
to the verification of experimental data as well as thefeasibility of the researches on 
oral drugs.  
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Introduction 
Diabetic foot is a general term for a series of clinical manifestations of the foot 
caused by peripheral vascular disease, neuropathy,and infection in diabetic patients 
due to long-term and chronically elevated blood glucose, including foot ulcers, 
infection and deep tissue destruction.Once diabetic foot occurs, it is difficult to treat, 
with the high cost and poor prognosis. If the treatment is not timely or adequate, there 
is often a risk of amputation.Diabetic foot is one of the main complications of 
diabetes. According to the IDF diabetes map (9th edition), about 463 million adults 
worldwide suffered from diabetes in 2019, and it is estimated that 700 million people 
could have diabetes by 2045 Figure 1.1 shows the global distribution of diabetes 
patients in 20191.      
At the national level, the top three countries with diabetes in 2019 were China, 
India and the United States, with about 118 million, 78 million and 30 million 
diabetics (20-79 years old), respectively. And China and the United States also have a 
  
high expenditure with diabetics.1 Figure 1.2 shows the top 10 countries with the 
highest number of diabetes in 2019. Based on the above data, the number of diabetes 
patients in Asia is the first in the world.  
In global diabetes research, the study of American forces dominates. Diabetes 
research in China in the number of papers and patents statistics on has and Germany 
are close to, or more than these countries, but from the paper quality in new drug 
research and clinical research level, with Europe and the United States and other 
developed countries have a certain gap. (2) 
Because Asian countries the number of diabetes and the number of concurrent 
with diabetic foot ulcers are more, but at this stage of clinical research level is not 
high, the number of new drug research, research direction is fuzzy, therefore decided 
to Asian drug therapy for diabetic foot ulcers group scoping review, to provide 
reference for drug treatment for the future research direction. 
A scoped review is a design approach "to rapidly map the key concepts 
underpinning the research field as well as the key resources and types of available 
evidence" (3). This scoping review is to summarize the current clinical research 
literature on Chinese medicine and western medicine for diabetic foot treatment in 
Asia, so as to provide new ideas for the future research direction of diabetic foot 
medicine in Asia and facilitate the further development of research. 
Methodology 
Eligibility Criteria 
Literature including nearly five years (2015-2019) in four databases of free text 
articles. Literature type limited to the clinical trial. Intervention limited to 
drugtreatment. Study design limited to randomized controlled trials. The population 
limit for Asians, any gender, most was over 35 years old, and the study population 
was limited to 30 or more (N > 30). 
Search Strategy 
The databases used are CNKI (China National Knowledge Infrastructure), 
PubMed and CQVIP (China Science and Technology Journal Database), Wanfang 
Data Knowledge Service Platform. 
In the process of visual search of three databases, the search of the literature will 
be stopped until the literature in the database does not conform to the content of the 
literature required by the re problem which is researched. 
The search strategy is based on the review of the clinical research progress of 
Chinese and western medicine in treating diabetic foot and the management of 
diabetic foot ulcers and extends to the differences in the treatment of diabetic foot 
with Chinese and western medicine. (4)(5) The common terms used in different 
databases include diabetic foot (including diabetes foot); broad terms such as non-
surgical debridement agents; narrower terms such as hydrogels. The literature 
published after 2015 was searched until all the required literature was retrieved. 
Study Selection 
Three researchers examined the search records of the first layer cooperatively, at 
the first place screening by the published date, title and abstract, secondly, by full text. 
When a disagreement arises between the researchers, the controversial papers should 
first be retained and then screened according to drug type of the papers as well asa 
comparison of the literature describing the same classification of drugs. 
Charting the Data 
  
Before the data analysis, two articles were used to discuss the process of data 
analysis. After collecting the data, three researchers summarized, analyzed and 
compared, and agreed on the types of data items including drug therapy, study method, 
inclusion and exclusion criteria of participants (not included in the report) and 
treatment results. 
Results 
The purpose of this scoping review is to summarize the existing studies on drug 
therapy (western medicine and Chinese medicine) for diabetic foot patients in Asia, so 
as to provide references for future research directions on drug therapy and the 
combination of Chinese and western medicine. Figure 3.1 shows the process of 
identifying, screening, including, and excluding literature. Ten available literature 
remained. 
Components of Drug Therapy 
After screening, 10 articles and 9 drugs for treating diabetic foot ulcers were 
retained. There were 5 kinds of western medicines, includingAdipose-Derived Stem 
Cell–Hydrogel Complex, Hyperbaric oxygen therapy, Acellular dermal matrix, 
Alprostadil, Salvianolate. Chinese medicine prescription 4 kinds, including 
TaohongSiwu Decoction,Simiao Yong＇an Decoction, HuangqiGuizhiWuwu Tang, 
WuweiXiaodu drink. TaohongSiwu Decoction has two pieces of literature, while 
other medicines only have one. Table 3.1 shows the nine drugs and their effects in 
treating diabetic foot. 
Drug therapy Effects literature 
Adipose-Derived Stem 
Cell–Hydrogel 
Complex 
Promote granulation tissue 
formation, epithelialization, 
and angiogenesis, thereby 
promoting wound healing. 
Potential of Allogeneic Adipose-
Derived Stem Cell–Hydrogel 
Complex for Treating Diabetic 
Foot Ulcers (6) 
 
Hyperbaric oxygen 
therapy 
Increase tissue oxygen level, 
accelerate wound healing, 
reduce edema, kill anaerobic 
bacteria. 
A Pilot Study of Short-Duration 
Hyperbaric Oxygen 
Therapy to Improve HbA1c, 
Leukocyte, and Serum 
Creatinine in 
Patients with Diabetic Foot 
Ulcer Wagner 3-4 (7) 
 
Xenogeneic(porcine) 
acellular dermal 
matrix(ADM) 
Prevent pollution, promote 
blood supply reconstruction 
and increase cell 
regeneration. 
Application effect of the 
xenogeneic ( porcine) acellular 
dermal matrix in the repair of 
diabetic foot ulcer (8) 
 
Alprostadil By activating adenylate 
cyclase to promote vascular 
dilation, inhibit platelet 
aggregation, improve 
microcirculation. 
Analysis of the effect of 
alprostadil on diabetic foot (9) 
Salvia miltiorrhiza 
polyphenols 
Effectively improve 
microcirculation, increase 
microvascular blood flow, 
Effects of Salvia miltiorrhiza 
polyphenols for injection 
Adipose-Derived Stem Cell–
  
and anticoagulation effect. Hydrogel Complex 
and collagen sponge in the 
diabetic foot (10) 
TaohongSiwu 
Decoction 
Vasodilation,anti-
inflammation, anti-fatigue, 
anti-shock, regulation of 
immune function, lipid 
reduction, supplementation 
of trace elements, anti-
allergic effect. 
The clinical curative effect of 
modified peach Tao Hong Siwu 
decoction and lipoic acid 
injection on diabetic foot (DF) 
in 50 cases (11) 
 
 
Jiawei Si Miao Yong 
An Decoction 
Or Simiao Yong＇an 
Decoction 
Resist inflammation, regulate 
blood coagulation and 
immunity, reduce blood 
glucose and inhibit bacteria, 
strengthen erythrocyte 
deformability, improve 
microcirculation and 
scavenging free radicals. 
Clinical Observation of Jiawei 
Si Miao Yong An Decoction in 
the Treatment of Diabetic Foot 
Ulcer of Lower limb (12) 
 
Research of intervention by 
Simiaoyong’an decoction for 
vascular endothelial function in 
the diabetic foot(13) 
 
HuangqiGuizhiWuwu 
Tang 
Improve the vascular 
function and hemodynamics 
of lower limbs, have certain 
anti-inflammatory and 
oxidative stress effects and 
reduce the injury of vascular 
endothelial cells. 
Clinical Effect of Modified 
HuangqiGuizhiWuwu Tang on 
Patient with Lower-extremity 
Arterial Disease (14) 
 
 
WuweiXiaodu Drink Play an active role in 
antibacterial and anti-
inflammatory, and inhibits 
the inflammatory response of 
patients. 
Clinical observation on 
treatment of type 2 diabetic foot 
ulcer by adding or subtracting 
WuweiXiaodu Drink combined 
with tissue engineering full-
thickness skin (15) 
 
Table 3.1Nine drugs or prescriptions and their effects in treating diabetic foot. 
 
Experimental design 
The experimental designs were based on the route of drug use, different 
experimental sites, and the degree of disease. Comparing different experimental 
designs needed to be done from different aspects, thus the following table 3.2 and 
table 3.3 discussed the ten literature from the number of participants, age of 
participants, experimental location, country, degree of the lesion in patients and 
specific experimental operation. 
 Number of 
participants 
Age of 
participants 
(Unit: year-
old) 
Experimental 
location 
Country Degree of 
lesion of 
patients 
  
Adipose-
Derived Stem 
Cell–Hydrogel 
Complex (6 
44 18-80 1.  Yonsei University 
Severance Hospital 
2.  Eulji General 
Hospital 
3. Asan Medical 
Center 
4. Korea University 
Guro Hospital 
Korea Type of 
diabetes: type 
1 or type 2 
diabetes; 
Ulcer duration: 
longer than 4 
weeks for the 
history of ulcer 
at screening; 
Wound size: 
between 1 and 
25 cm2; 
Wound depth 
of Wagner 
grade 1 and 2 
Hyperbaric 
Oxygen Therapy 
(7) 
30 20-79 Institutional Review 
Board of Medical 
Faculty of Udayana 
University and 
Sanglah General 
Hospital Denpasar 
Indonesia Diabetic foot 
ulcer (DFU) 
Wagner 3-4 
Xenogeneic(por
cine) acellular 
dermal matrix 
(8) 
76 18-68 Shizuishan first 
people's hospital of 
Ningxia hui 
autonomous region 
China Diabetic foot 
ulcer (DFU) 
Wagner 2-3 
DFU 
Wagner2: 47 
DFU 
Wagner3: 29 
Alprostadil  (9) 100 Male: 48-81 
Female: 43-
78 
Shanghai Ruijin 
rehabilitation hospital 
China  
Salvia 
miltiorrhiza 
polyphenols for 
injection and 
collagen sponge 
(10) 
115 44-72 Metabolic disease 
hospital of Tianjin 
medical university 
China Diabetic foot 
ulcer (DFU) 
Wagner 2-3 
TaohongSiwu 
Decoction (11) 
100 44-76 Pinghu hospital of 
traditional Chinese 
medicine 
 
China Diabetic foot 
ulcer (DFU) 
Wagner 0-1 
Simiao Yong＇
an Decoction 
(13) 
50 >60 Henan Province 
Hospital of TCM 
China  
Jiawei Simiao 
Yong＇an 
Decoction  (12) 
86 58-74 People's hospital of 
Wuhan university 
China Diabetic foot 
ulcer (DFU) 
Wagner 1-4 
HuangqiGuizhi 128 64-74 Weifang People's Ho China Fontaine stage 
  
Table 3.2 The basic information of all the experiments. 
 
Wuwu Tang 
(14) 
spital I to III 
WuweiXiaodu 
drink (15) 
150 41-63 Department of 
dermatology, 
Cangzhou central 
hospital, Hebei 
province 
 
China Diabetic foot 
ulcer (DFU) 
Wagner 3-4 
 Specific experimental operation 
Adipose-
Derived Stem 
Cell–Hydrogel 
Complex (6) 
Of the 44 participants, 25 were assigned to the experimental group and 19 
were assigned to the matched group. 3 participants in the experimental 
group and 2 participants in the matched group were excluded because they 
did not reach high blood glucose levels (>450).   Patients of both groups 
were treated with 3% hydrogen peroxide and a saline solution to remove 
dirt and other debris from their ulcers, and both groups were covered with 
polyurethane foam. The difference between the two groups' patients was 
that the experimental group used allograft ASC sheets as the primary 
dressing and the matched group used mesh polyurethane films with 
silicone adhesives as the primary wound dressing. In both groups, drugs 
were changed once a week. If necessary, patients could go to the hospital 
to check the wound two or three times a week. If there were any adverse 
reactions,  the auxiliary dressing could be replaced. 
Hyperbaric 
Oxygen 
Therapy (7) 
Blood tests were performed on all patients to detect HbAlc levels, white 
blood cell counts and serum creatinine levels before debridement, and they 
were divided into two groups. Among them, the experimental group 
conducted ten courses of HBOT(One session of HBOT uses oxygen at 2.4 
ATA for 90 minutes per day at several hyperbaric chambers) and the 
matched group adopted the standard treatment. Five courses of treatment 
per week, it took two weeks altogether. 
Xenogeneic(po
rcine) acellular 
dermal matrix 
(8) 
All participants were given anti-infection, nutritional support treatment, 
diabetes specialist guidance diabetic diet, insulin treatment, monitoring and 
regulating blood sugar，wound secretion culture-sensitive antibiotics 
guide treatment as well as other comprehensive systemic treatment.  The 
wound surface was washed with 1.5% hydrogen peroxide solution, iodine-
volt solution and 0.9% sodium chloride solution in turn, and the wound 
surface was wrapped and fixed with gauze, and the dressing was changed 
once a day. 
Experimental group:  One week later, under subarachnoid anesthesia and 
spinal anesthesia, the Sonoca180 low-frequency ultrasonic debridement 
device (produced by Germany surin-cieser company) was applied to 
debridement of the diabetic foot, and the wound surface was expanded and 
created stealthily. Clipping heterogeneous (swine) ADM size bigger than 
wound for 2 ~ 3 cm, then used 0.9% sodium chloride solution cleaning the 
wound for three times, the duration of cleaning was about 3 min, then soak 
in dilute iodine volts fluid (liquid iodine volts: 0.9% sodium chloride 
  
solution is 1:1) for 1 min, guarantee level toward the wound in the 
heterogeneous skin, fully cover the wound, external use sterile dressings 
bandage fixation after six floors, 1 week to replace one. 
Matched group:The matched group was treated with sulfadiazine silver 
cream (1% sulfadiazine silver, 60 g, Guangdong Hengjian pharmaceutical 
co., LTD.).8 
Alprostadil  (9) Of the 100 participants, 50 were assigned to the experimental group and 50 
to the matched group. Patients in both groups received conventional 
treatment and were treated with hypoglycemic drugs. The wounds were 
washed with normal saline and hydrogen peroxide, and the wound was 
wrapped with iodoform gauze. Both groups dissolved 20ml tanshinone 
injection in normal saline, and the patients were given intravenous infusion 
once a day. The difference between the two groups was that the 
experimental group was treated with alprostadil injection, 100mg of 
alprostadil injection was dissolved in saline, and the patients were given 
intravenous infusion once a day. Patients were treated for 2 weeks and the 
results were reviewed. 
Salvia 
miltiorrhiza 
polyphenols 
for injection 
and collagen 
sponge (10) 
Of the 115 participants, 60 were assigned to the matched group and 55 to 
the experimental group. Patients in both groups were treated with 
conventional type 2 diabetic foot therapy, wound cleaning, and spraying 
0.9% sodium chloride solution on the wound with the same type of 
antibiotic. The difference between the two groups was that the patients in 
the experimental group were treated with collagen dressing, dissolved 200 
mg Danshen polyphenols in 5% glucose injection, and given intravenous 
infusion once a day. For four weeks of one course of treatment, patients' 
ulcer recovery before and after treatment and during treatment were 
observed after two courses of treatment. 
TaohongSiwu 
Decoction (11) 
All participants received basic treatment for diabetes, including diet 
control, insulin control of blood glucose, and decompression therapy. Foot 
superficial ulcer was disinfected with iodophor, local antibiotics were 
given wet compress,  and on this basis, the experimental group was given 
Tao Hong Siwu Decoction(Tao Ren 30g, Hong Hua 30g, Dang Gui 30g, 
Chuanxiong 20g, Shu Di Huang 20g, Shen Jin Cao 30g, Hai Feng Teng 
30g, Ai Ye 30g), which was fried and soaked in feet once a day for 15 
minutes each time. At the same time, the blood flow velocity of the dorsal 
foot artery and sensory conduction velocity of the common peroneal nerve 
and superficial peroneal nerve were measured before and after treatment. 
Simiao 
Yong＇an 
Decoction (13) 
All patients were given diabetes education and a diabetic diet, and the 
experimental group was given Simiao Yong＇an Decoction (Dang Gui 
30g, Xuan Shen 15g, Huang Qi 15g, Jin Yin Hua 15g, Ji Xue Teng 15g, 
Gan Cao 6g) which was fried in water, one dose per day and separated one 
dose for two times. In the meantime,  the matched group was not given any 
medication. 
Jiawei Simiao 
Yong＇an 
Decoction  
(12) 
Of the 86 participants, 43 were assigned to the experimental group and 43 
to the matched group. Patients in the two groups were first given 
conventional treatment to control their blood glucose, and the same 
antibiotics were selected to control infection. Physical methods and drugs 
were used to improve the blood circulation in the lower extremities of the 
  
Table 3.3 The details of all the experimental designs. 
Discussion 
Nine different Chinese medicines and western medicines were used to treat 
diabetic foot. In the above paragraphs, different Chinese medicines and western 
medicines were compared one by one. Next, this section will analyze 10 articles used 
to determine the research direction of treating diabetic foot in the future. 
In “The Potential of Allogeneic Adipose-Derived Stem cells - Hydrogel 
Complex for Treating Diabetic Foot Ulcers”(6), the author said research is likely to be 
patients. The ulcer of the patients was changed once a day, and the patients 
were given cilostazol tablets twice a day, 100mg each time. The difference 
between the two groups of patients was that the experimental group took 
modified Simiao Yong＇an Decoction orally (Yin Chen 15g,Chui Pen Cao 
30g, Pu Huang 10g, Sheng Mu Li 30g, Dang Gui 10g, Xuan Shen 15g, Chi 
Shao 10g, ChuanNiu Xi 15g, Tu Fu Lin 30g, Yi Yi Ren 30g, Xi Lian Cao 
30g, Huang Lian 9g, Rou Gui 4.5g), once a day, and took 200ml in the 
morning and evening. 
HuangqiGuiZh
iWuwu Tang 
(14) 
Of the 128 participants, 64 were assigned to the experimental group and 64 
to the matched group. Two groups of patients simultaneously received non-
drug treatment, control of blood glucose, blood pressure, blood lipid, and 
other drug treatment. Patients were given probucol tablets at breakfast and 
dinner with 0.5g each time. Oral aspirin enteric-coated tablets were taken 
100mg per day for 3 months. Intravenous infusion of alprostadil injection, 
10 mg a day, plus 10ml normal saline, continuous injection for 15 days, 15 
days rest for a course of treatment, a total of 3 courses of treatment. The 
difference between the two groups was that the experimental group was 
given orally modified HuangqiGuizhiWuwu soup (Huang Qi 30g, GuiZhi 
10g, Bai Shao 15g, Sheng Jiang 10g, Da Zao 10g, Tian Hua Fen 15g, Tai 
Zi Shen 20g, Di Long 10g, Ji Xue Teng 30g, Dan Shen 20g, Quan Xie 5g, 
Gan Cao 5g). Fu Ling 20g, Kun Bu 10g, Bai Jiang Can 10g were added to 
patients with phlegm, which were prone to fatigue and physical weakness. 
Patients who did not want to speak were added to Dang Shen 15g, Chao 
Bai Zhu 15g. Patients with hot chest, palm and foot were added to Xuan 
Shen 15g and Mu Dan Pi 15g. Soak the medicine in water for 30min and 
cook it twice a day. Take 150ml each morning and evening. Both groups 
received continuous treatment for 3 months. 
WuweiXiaodu 
Drink (15) 
Of the 150 participants, 75 were assigned to the experimental group and 75 
to the control group. Patients in the two groups were given insulin injection 
at the same time, 20 units a day, and subcutaneously injected at 3 times in 
the morning, the middle and the evening 30 minutes before the meal, and 
the patients were given tissue engineering full-layer skin treatment. The 
difference between the two groups was that the experimental group was 
treated with WuweiXiaodu drink ( Jin Yin Hua 30g, Ye Ju Hua 30g, Pu 
Gong Ying 30g, Dang Gui 20g, Tian Hua Fen 20g, Lian Qiao 15g, Dong 
Kui Zi 15g, Mu Dan Pi 15g, Niu Xi 15g, Bai Shao 15g, Bai Zhi 15g, 
Huang Qin 15g, Zi Hua Di Ding 10g, San Qi Fen 3g). For patients with 
pain, add 10g Sheng Ru Xiang and 10g Sheng Mo Yao. For patients with 
blood stasis, add Chi Shao 10g and Ji Xue Teng 15g. Take 150ml each 
morning and evening. Both groups were treated for 8 weeks. 
  
the first report to prove Allogeneic Adipose-Derived Stem Cell for the effectiveness 
of the treatment of diabetic foot ulcers.So, the study has limitations, the action 
mechanism of allogeneic adipose-derived stem cells still need to be further confirmed. 
In the study of short-duration hyperbaric oxygen therapy(7), the author found that the 
glucose metabolism and the mechanism of improving human renal function were still 
unclear, and further studies were needed to determine the effect of short-duration 
hyperbaric oxygen therapy on diabetic foot ulcer patients. When using the 
xenogeneic(porcine) acellular dermal matrix to repair diabetic foot ulcers(8), it can 
not only shorten the wound healing time, reduce the number of dressing changes, but 
also reduce the psychological and economic burden of patients and reduce the 
infection rate.At the same time, it has wide sources, simple operation, and low price, 
and is worthy of clinical promotion. In the study of alprostadil(9), it has been 
determined that alprostadil has a better clinical effect and higher safety. Research 
shows that alprostadil is worthy of extensive application in clinical practice. In the 
process of studying salvia miltiorrhiza polyphenols for injection and collagen 
sponge(10), the direct therapeutic effect of salvianolic on diabetic foot still needs 
further study, but it can improve microcirculation, prevent microthrombosis, regulate 
vascular endothelial dysfunction and other effects have been able to play a positive 
role in the treatment of diabetic foot.The combination of salvianolic and collagen 
sponge played an active role in the treatment and healing of diabetic foot. In the 
process of studying of the TaohongSiwu Decoction(11), it has proved 
flavoredTaohongSiwu Decoction combined thioctic acid injection on diabetic foot has 
good effect, but the author use samples is limited, did not add the diabetic foot higher 
severity of patients, so in further research, more data are needed to determine the 
curative effect of TaohongSiwu Decoction. In the two articles of Simiao Yong＇an 
Decoction, Jia Wei Simiao Yong＇an Decoction can improve the microvascular 
lesions of diabetic foot by repairing the damaged intima of arteries(12), inhibiting 
inflammation(13), and so on, so that diabetic foot can be relieved. However, the 
literature on Simiao Yong 'an Decoction is still very limited, and the molecular 
mechanism of Simiao Yong 'an Decoction remains to be further studied. In the study 
of HuangqiGuizhiWuwu Tang(14), it was proved that HuangqiGuizhiWuwu drink 
could improve the vascular function and hemodynamics of the lower extremities, 
reduce the injury of vascular endothelial cells, and thus play a role in alleviating the 
progression of diabetic lower extremity vascular diseases.It is worthy of clinical 
promotion and application of such drugs. In the process of studying WuweiXiaodu 
drink combined with tissue engineering full-thickness skin (15), it has been 
determined that it can improve the efficacy, improve the patient's condition and play 
an anti-inflammatory role without obvious adverse reactions. Therefore, it is a drug 
worthy of clinical promotion. 
Drug therapy Total effective rate 
Adipose-Derived Stem Cell–Hydrogel 
Complex (6) 
Matched group: 47%( 8/17 ) 
 
Experimental group: 73% ( 16/22 ) 
 
Hyperbaric oxygen therapy (7) Matched group: 
HbA1c levels: 
Baseline: 10.98± 2.37 
Effect size: 1.28± 1.54 
  
Leukocyte count: 
Baseline: 14.27± 6.79 
Effect size: 3.26± 7.76 
Serum creatinine levels: 
Baseline: 0.73± 0.25 
Effect size: 0± 0.13 
Experimental group: 
HbA1c levels: 
Baseline: 9.42± 1.96 
Effect size: 2.34± 1.57 
Leukocyte count: 
Baseline: 13.97± 6.24 
Effect size: 5.13± 6.72 
Serum creatinine levels: 
Baseline: 2.10± 2.88 
Effect size: 0.05± 0.45 
Xenogeneic(porcine) acellular dermal 
matrix (8) 
Matched group: 78.95% ( 30/38 ) 
Experimental group: 94.74% ( 36/38 ) 
Alprostadil (9) Matched group: 78% ( 39/50 ) 
Experimental group: 98% ( 49/50 ) 
Salvia miltiorrhiza polyphenols for 
injection and collagen sponge(10) 
Matched group: 30.91% (22/60 ) 
Experimental group: 60% ( 33/55 ) 
TaohongSiwu Decoction (11) Matched group: 68% ( 34/50 ) 
Experimental group: 84% ( 42/50 ) 
Simiao Yong＇an Decoction (12) Matched group: 
ET-1 (pg/ml): 52.06± 5.32 
NO(μmol/L): 67.15± 2.93 
TXB2(pg/ml): 84.02± 3.99 
6-Keto-PGF1α(pg/ml): 72.55± 3.89 
Experimental group: 
Before the treatment: 
ET-1 (pg/ml): 74.09± 4.87 
NO(μmol/L): 54.18± 7.97 
TXB2(pg/ml): 101.60± 9.78 
6-Keto-PGF1α(pg/ml): 65.07± 5.83 
After the treatment: 
ET-1 (pg/ml): 62.05± 4.78 
NO(μmol/L): 65.81± 3.83 
TXB2(pg/ml): 91.84± 8.90 
6-Keto-PGF1α(pg/ml): 70.77± 7.00 
Jiawei Si Miao Yong An Decoction (13) Matched group: 86.05% ( 37/43 ) 
Experimental group: 93.02%( 40/43 ) 
HuangqiGuizhiWuwu Tang (14) Matched group: 92.2% ( 59/64 ) 
Experimental group: 100% ( 64/64 ) 
WuweiXiaodu drink combined with Matched group: 73.33%( 55/75 ) 
  
tissue engineering full-thickness skin (15) Experimental group: 86.67%( 65/75 ) 
Table 3.4 The total effective rate of all the experiments. 
Conclusion 
The purpose of the scoping review is to review the general situation of a certain 
research field, based on this paper, the principal contradiction discussed in this paper 
is comparing the researches of partial traditional Chinese medicine and western 
medicine treatment of the diabetic foot.Through studied and thought of these ten 
pieces of literature, some problems emerged obviously.The first problem was that the 
literature of diabetic foot in China was deficient. On the one hand, the quantity of 
literature in China may be considerable, on the other hand, the quality was 
dissatisfactory. These were two pieces of literature that had some statistical errors, 
both of these two pieces of literature were written by Chinese researchers. 
Proportionately, this kind of error maybe not only existed in the 10 literature but had a 
big amount in the published literature in China. The second problem was that the 
research of diabetic foot in Asia was not enough. According to the approach of 
PUBMED searches, a total of 60 articles were excluded from 33 because of 
geographical conditions.The third problem was that most of the literature that meets 
the requirements of this theme were cited fewer times, even some literature hasn’t 
been cited before. That confirmed the lack of research on diabetic foot in Asia from 
another perspective and the low quality of that literature.To sum up, this scoping 
review proves that there was still a big loophole in the quality of research on diabetic 
foot in Asia. 
Abbreviation:CNKI = China National Knowledge Infrastructure; CQAIP = China 
Science and Technology Journal Database; WANFANG DATA =Wanfang Data 
Knowledge Service Platform 
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APPENDIX : 
FIGURES: 
Figure 1.1 Number of diabetes patients worldwide (20-79 years old) in 2019（1） 
 
 
  
 
Figure 1.2 Top 10 countries with the highest number of diabetics in 2017 (the red bar 
represents health spending)（1） 
 
 
Figure 3.1Process of identifying, screening, including, and excluding literature. 
  
 
 
 
 
